Tulane Cancer Center/LCRC Seminar Series
Tulane Cancer Center Office of Clinical Research
Louisiana Cancer Research Consortium
Associate Dean for Clinical Research and Training
Tulane University Community Health Center at Covenant House
Clinical and Translational Research, Education and Commercialization Project (CTRECP)
![]() Samir S. El-Dahr, M.D.Professor of Pediatric Nephrology |
Biographical Narrative:
Dr. El-Dahr's research efforts are centered on the molecular mechanisms of renal cell differentiation. In particular, he is interested in defining the transcription factors involved in terminal renal epithelial cell differentiation. Recently, he identified the p53 transcription factor as an important regulator upstream of several renal function genes. Mutations in the p53-binding site of the human bradykinin B2 receptor promoter are associated with hypertension and end-stage-renal disease. Thus, p53 may link renal cell differentiation and functional maturation. These findings also suggest a possible novel link between cancer susceptibility and the development of renal disease and hypertension. Another aspect of his work is to define the cellular and molecular pathways leading to renal dysplasia in a mouse model of renal dysgenesis in mice lacking a GPCR, the bradykinin B2 receptor. Of particular interest is the aberrant activity of EGF-R function in this model of renal dysgenesis, thus mimicking human cystic renal dysplasia. Dr. El-Dahr has generated a mouse model of an important human renal disease that accounts for about 30% of all childhood chronic renal failure.
Selected Publications:
Tulane University, New Orleans, LA 70118 504-865-5000 website@tulane.edu